Proxalutamide

[speranza10]

Do you happen to have any updated news on the studies of this drug? Years ago I read very positive things, it was even said that there would be the same improvement that we had from switching from casodex to xtandi. So it was hoped that it would be much more effective than enzalutamide, and instead it seems to have disappeared into thin air.

[petrig]

I found this:"...These findings preliminarily showed the promising antitumor activity of proxalutamide in patients with mCRPC with a manageable safety profile. The proxalutamide dose of 200 mg daily is recommended for future phase 3 trial (Clinical trial registration no. CTR20170177)."So I think its in phase 3(III) trial.

[speranza10 in reply to petrig]

Thanks for the information, if it is in phase 3 it is a good sign, let's hope so.

[j-o-h-n]

Proxalutamide FROM A I

ChatGPT said:

ChatGPT

Proxalutamide is a synthetic nonsteroidal antiandrogen that has been studied primarily for its potential use in treating prostate cancer and other conditions related to androgen receptor signaling. It works by blocking the action of androgens (such as testosterone) at the androgen receptor, which can be useful in conditions where androgens promote disease progression, like in prostate cancer.

Proxalutamide has also been investigated for other potential applications, such as in treating conditions related to excessive androgen activity, like androgenic alopecia (male pattern baldness), and for use in managing some other hormone-driven conditions.

As with any experimental drug, clinical studies are important to determine the safety and efficacy of proxalutamide for various uses. If you're considering or have been prescribed proxalutamide, it is crucial to follow medical advice and guidelines to ensure appropriate use.

Good Luck, Good Health and Good Humor.

j-o-h-n